Dr. Sneha Ramakrishna, MD
Claim this profileStanford University
Studies Neuroblastoma
Studies Osteosarcoma
4 reported clinical trials
5 drugs studied
Area of expertise
1Neuroblastoma
Stage IV
HLA-A positive
MAGE-A4 positive
2Osteosarcoma
Stage IV
HLA-A positive
MAGE-A4 positive
Affiliated Hospitals
Clinical Trials Sneha Ramakrishna, MD is currently running
B7-H3CART
for Solid Tumors
The purpose of this study is to test the manufacturing feasibility and safety of intravenous (IV) administration of B7-H3CART in children and young adult subjects with relapsed and/or refractory solid tumors expressing B7-H3 target using a standard 3+3 dose escalation design.
Recruiting1 award Phase 13 criteria
GD2 CAR T Cells
for Brain and Spinal Cord Gliomas
The primary purpose of this study is to test whether GD2-CAR T cells can be successfully made from immune cells collected from children and young adults with H3K27M-mutant diffuse intrinsic pontine glioma (DIPG) or spinal H3K27M-mutant diffuse midline glioma (DMG). H3K27Mmutant testing will occur as part of standard of care prior to enrollment.
Recruiting1 award Phase 18 criteria
More about Sneha Ramakrishna, MD
Clinical Trial Related2 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Sneha Ramakrishna, MD has experience with
- B7-H3CART
- Afamitresgene Autoleucel
- Cyclophosphamide
- Fludarabine
- GD2 CAR T Cells
Breakdown of trials Sneha Ramakrishna, MD has run
Sarcoma
Neurofibrosarcoma
Synovial Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sneha Ramakrishna, MD specialize in?
Sneha Ramakrishna, MD focuses on Neuroblastoma and Osteosarcoma. In particular, much of their work with Neuroblastoma has involved Stage IV patients, or patients who are HLA-A positive.
Is Sneha Ramakrishna, MD currently recruiting for clinical trials?
Yes, Sneha Ramakrishna, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Sneha Ramakrishna, MD has studied deeply?
Yes, Sneha Ramakrishna, MD has studied treatments such as B7-H3CART, Afamitresgene autoleucel, Cyclophosphamide.
What is the best way to schedule an appointment with Sneha Ramakrishna, MD?
Apply for one of the trials that Sneha Ramakrishna, MD is conducting.
What is the office address of Sneha Ramakrishna, MD?
The office of Sneha Ramakrishna, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.